Very early posttraumatic serum alterations are significantly associated to initial massive RBC substitution, injury severity, multiple organ failure and adverse clinical outcome in multiple injured patients

European Journal of Medical Research

P Biberthaler¹  W Mutschler¹  BA Leidel¹  C Kirchhoff¹  K-G Kanz¹  L Keil¹  V Bogner¹ 

[1] Chirurgische Klinik und Poliklinik Innenstadt, Ludwig-Maximilians-University, Munich, Germany

关键词: Clinical Outcome;    Il-10;    Il-8;    Il-6;    Blood Transfusion;    Multiple Trauma;   

Others  :  1093684
DOI  :  10.1186/2047-783X-14-7-284

 received in 2008-11-07, accepted in 2009-04-29,  发布年份 2009

【 摘 要 】

Background

Multiple severe trauma frequently leads to massive dysbalances of the human immune system. This phenomenon is known as "Systemic Inflammatory Response Syndrome (SIRS)". SIRS is connected to multiple organ failure and thereby entails higher morbidity and mortality in trauma patients. Pro-and anti-inflammatory cytokines such as Il-6, Il-8 and Il-10 seem to play a superior role in the development of SIRS. Several studies support the hypothesis that the very early cytokine release pattern determines the patients' subsequent clinical course. Most data about interleukins in trauma patients however refer to serum concentrations assessed sometime in the first 24 h, but there is only little information about release dynamics in a small-meshed time frame in the very initial post-trauma period.

Patients and methods

58 multiple injured patients (Injury Severity Score > 16 points) were included. Blood samples were drawn on patient admission (not later then 90 minutes after trauma) and at 6 h, 12 h, 24 h, 48 h and 72 h. Il-6, Il-8 and Il-10 were measured using an automated chemiluminescence assay (IMMULITE, Siemens Healthcare Diagnostics GmbH). Interleukin levels were correlated to distinct epidemiological and clinical parameters.

Results

Interleukin serum concentrations are thoroughly elevated after trauma. Patients with haemorrhagic shock and consecutive massive RBC substitution (n = 27) exhibit higher Il-6, Il-8 and Il-10 levels as compared to patients with minor RBC transfusion extent (n = 31). Interleukin levels also differentiate patients with MOF (n = 43) from such without MOF (n = 15) already at the earliest post trauma time (90 minutes). Il-6, Il-8 and Il-10 concentrations also significantly distinguish patients with adverse outcome (n = 11) from such with favourable outcome (n = 47). Exclusively Il-10 has significant correlation to injury severity (ISS > 35).

Conclusion

The current study presents an image of the serum Il-6, 8 and 10 releases in multiple trauma patients in the very early post-trauma period. We could thereby demonstrate that interleukin levels can clearly differentiate the presence of hemorrhagic shock and subsequent massive blood product substitution, the development of multiple organ failure and clinical outcome. No significant connection to age, gender and brain injury could be detected. Most importantly, changes in interleukin levels can be observed in the very early posttraumatic phase, at the earliest 90 minutes after trauma.

【 授权许可】

   
2009 I. Holzapfel Publishers

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Akkose S, Ozgurer A, Bulut M, Koksal O, Ozdemir F, Ozguc H: Relationships between markers of inflammation, severity of injury, and clinical outcomes in hemorrhagic shock. Adv Ther 2007, 24(5):955-962.
• [2]Avall A, Hyllner M, Bengtson JP, Carlsson L, Bengtsson A: Postoperative inflammatory response after autologous and allogeneic blood transfusion. Anesthesiology 1997, 87(3):511-516.
• [3]Barklin A: Systemic inflammation in the brain-dead organ donor. Acta Anaesthesiol Scand 2009, 53:425-435.
• [4]Baue AE, Durham R, Faist E: Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 1998, 10(2):79-89.
• [5]Baue AE, Durham R, Faist E: Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 1998, 10(2):79-89.
• [6]Biberthaler P, Bogner V, Baker HV, et al.: Genome-wide monocytic mRNA expression in polytrauma patients for identification of clinical outcome. Shock 2005, 24(1):11-19.
• [7]Browatzki M, Pfeiffer CA, Schmidt J, Kranzhofer R: Endothelin-1 induces functionally active CD40 protein via nuclear factor-kappaB in human vascular smooth muscle cells. Eur J Med Res 2007, 12(3):129-133.
• [8]Committee on Injury Scaling (1990) Abbreviated Injury Scale 1990 Revision Des Plaines, Illinois: Association of the Advancement of Automovement Medicine; 2002.
• [9]Como JJ, Dutton RP, Scalea TM, Edelman BB, Hess JR: Blood transfusion rates in the care of acute trauma. Transfusion 2004, 44(6):809-813.
• [10]DeLong WG Jr, Born CT: Cytokines in patients with polytrauma. Clin Orthop Relat Res 2004, 422:57-65.
• [11]Dimopoulou I, Orfanos S, Kotanidou A, et al.: Plasma pro-and anti-inflammatory cytokine levels and outcome prediction in unselected critically ill patients. Cytokine 2008, 41(3):263-267.
• [12]Dunne JR, Malone DL, Tracy JK, Napolitano LM: Allogenic blood transfusion in the first 24 hours after trauma is associated with increased systemic inflammatory response syndrome (SIRS) and death. Surg Infect (Larchmt) 2004, 5(4):395-404.
• [13]Fransen E, Maessen J, Dentener M, Senden N, Buurman W: Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 1999, 116(5):1233-1239.
• [14]Gebhard F, Pfetsch H, Steinbach G, Strecker W, Kinzl L, Bruckner UB: Is interleukin 6 an early marker of injury severity following major trauma in humans? Arch Surg 2000, 135(3):291-295.
• [15]Giannoudis PV, Hildebrand F, Pape HC: Inflammatory serum markers in patients with multiple trauma. Can they predict outcome? J Bone Joint Surg Br 2004, 86(3):313-323.
• [16]Heiden S, Pfab T, von WK, et al.: Tissue specific activation of the endothelin system in severe acute liver failure. Eur J Med Res 2008, 13(7):327-329.
• [17]Joyce DA, Gibbons DP, Green P, Steer JH, Feldmann M, Brennan FM: Two inhibitors of proinflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 1994, 24(11):2699-2705.
• [18]Kamm K, Vanderkolk W, Lawrence C, Jonker M, Davis AT: The effect of traumatic brain injury upon the concentration and expression of interleukin-1beta and interleukin-10 in the rat. J Trauma 2006, 60(1):152-157.
• [19]Kirchhoff C, Buhmann S, Bogner V, et al.: Cerebrospinal IL-10 concentration is elevated in non-survivors as compared to survivors after severe traumatic brain injury. Eur J Med Res 2008, 13(10):464-468.
• [20]Kuhne CA, Ruchholtz S, Kaiser GM, Nast-Kolb D: Mortality in severely injured elderly trauma patients -when does age become a risk factor? World J Surg 2005, 29(11):1476-1482.
• [21]Lausevic Z, Lausevic M, Trbojevic-Stankovic J, Krstic S, Stojimirovic B: Predicting multiple organ failure in patients with severe trauma. Can J Surg 2008, 51(2):97-102.
• [22]Lederer JA, Rodrick ML, Mannick JA: The effects of injury on the adaptive immune response. Shock 1999, 11(3):153-159.
• [23]Lefering R, Goris RJ, van Nieuwenhoven EJ, Neugebauer E: Revision of the multiple organ failure score. Langenbecks Arch Surg 2002, 387(1):14-20.
• [24]Maier B, Lefering R, Lehnert M, et al.: Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock 2007, 28(6):668-674.
• [25]Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM: Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 2003, 54(5):898-905.
• [26]Mannick JA, Rodrick ML, Lederer JA: The immunologic response to injury. J Am Coll Surg 2001, 193(3):237-244.
• [27]Park MS, Salinas J, Wade CE, et al.: Combining early coagulation and inflammatory status improves prediction of mortality in burned and nonburned trauma patients. J Trauma 2008, 64(2 Suppl):S188-S194.
• [28]Rebulla P, Porretti L, Bertolini F, et al.: White cell-reduced red cells prepared by filtration: a critical evaluation of current filters and methods for counting residual white cells. Transfusion 1993, 33(2):128-133.
• [29]Roumen RM, Hendriks T, van d, et al.: Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993, 218(6):769-776.
• [30]Sauaia A, Moore FA, Moore EE, et al.: Epidemiology of trauma deaths: a reassessment. J Trauma 1995, 38(2):185-193.
• [31]Schinkel C, Faist E, Zimmer S, et al.: Kinetics of circulating adhesion molecules and chemokines after mechanical trauma and burns. Eur J Surg 1996, 162(10):763-768.
• [32]Schlosser HG, Volk HD, Splettstosser G, Brock M, Woiciechowsky C: A new qualitative interleukin-6 bedside test can predict pneumonia in patients with severe head injury--comparison to the standard Immulite test and a semiquantitative bedside test. J Neurosurg Anesthesiol 2007, 19(1):5-9.
• [33]Sherry RM, Cue JI, Goddard JK, Parramore JB, DiPiro JT: Interleukin-10 is associated with the development of sepsis in trauma patients. J Trauma 1996, 40(4):613-616.
• [34]Sperry JL, Friese RS, Frankel HL, et al.: Male gender is associated with excessive IL-6 expression following severe injury. J Trauma 2008, 64(3):572-578.
• [35]Steinbach G, Bolke E, Schulte am EJ, et al.: Comparison of whole blood interleukin-8 and plasma interleukin-8 as a predictor for sepsis in postoperative patients. Clin Chim Acta 2007, 378(1-2):117-121.